| Name | Title | Contact Details |
|---|
Daktari Diagnostics is a healthcare solutions company that enables enhanced disease management in both developed and developing countries. Our portable point-of-care diagnostic platform, with built-in wireless connectivity and an intuitive cloud-based data management system, provides the real-time information necessary to improve clinical outcomes for individual patients and support global disease elimination programs. Daktari`s initial products will target viruses of worldwide significance, including Hepatitis C and HIV. The company recently announced a Hepatitis C partnership with Merck & Co (MSD).
Recombinant Data Corp. is a Newton, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Ohio Bureau Of Workers' Compensation is a Independence, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
The Alaska Native Tribal Health Consortium is a not-for-profit tribal health organization managed by Alaska Native tribal governments and their regional health organizations.
scPharmaceuticals, based in Lexington, MA, is a privately held biopharmaceutical company developing a portfolio of transformative pharmaceutical products for subcutaneous delivery. Based on widely used generic drugs that currently require intravenous or intramuscular injections, our innovative products will be administered subcutaneously via a proprietary patch pump. This avoids material risks and costs associated with the current delivery options. Our lead products are the first subcutaneous formulations of furosemide (the most widely used parenteral diuretic in treating heart failure) and ceftriaxone (the most widely used parenteral antibiotic outside the hospital setting). Our novel furosemide formulation enables convenient anytime anywhere use, for example in an outpatient setting instead of the emergency room or other in-patient settings. For ceftriaxone and other antibiotics, subcutaneous administration eliminates the need for PICCs (peripherally inserted central catheters), which are associated with serious complications, frequent adverse events and high medical cost. For further information on how we are transforming the administration of parenteral drugs.